Phase IIa Clinical Biomarker Trial of Dietary Arginine Restriction and Aspirin in Colorectal Cancer Patients is a research paper published in Cancers (2023). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
University of California Irvine Department of Medicine, the National Cancer Institute of the National Institutes of Health
Grant: K23 CA133142
University of California Irvine Department of Medicine, the National Cancer Institute of the National Institutes of Health
Grant: P30 CA062203
University of California Irvine Department of Medicine, the National Cancer Institute of the National Institutes of Health
Grant: M01 RR00827
National Institutes of Health
Grant: 3P30CA062203-27S1
Clinical Trial Advancement and Development for Sarcomas
National Institutes of Health
Grant: 3M01RR000827-13S2
GENERAL CLINICAL RESEARCH CENTER - CAP
National Institutes of Health
Grant: 5K23CA133142-03
Risk reduction through polyamine inhibition among colorectal carcinoma patients
FWCI
0.99
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals